September 26, 2013
WASHINGTON, DC — At the inaugural LMG Life Sciences awards, Finnegan won the award for Intellectual Property Firm of the Year. Finnegan partner Charles E. Lipsey also received top honors for “Hatch-Waxman (Branded Pharmaceutical) Litigator of the Year.” The awards ceremony took place on Wednesday, September 25 in New York, where the Legal Media Group recognized and honored the leading attorneys, law firms, and in-house counsel teams that have played a significant role in the life sciences industry over the past year. During the last twelve months, Finnegan prevailed in pharmaceutical cases for Abbvie Inc., Cephalon, DuPont Nutrition Biosciences APS, Eli Lilly and Company, and Galderma. The firm is also involved in ongoing litigations at the district and federal courts for innovative drug companies such as AstraZeneca, Ferring BV, Grünenthal GmbH, Otsuka Pharmaceuticals, and Pronova BioPharma Norge AS.
In compiling its rankings, LMG Life Sciences spoke to in-house counsel, leading lawyers in the life sciences field and conducted extensive research of public records. The publication conducted nearly 1000 interviews and reviewed surveys completed by lawyers active in the areas of pharmaceuticals, medical devices, and biotechnology.
With more than 375 intellectual property lawyers, Finnegan is one of the largest IP law firms in the world. From offices in Washington, DC; Atlanta, Georgia; Boston, Massachusetts; Palo Alto, California; Reston, Virginia; Brussels, Belgium; Shanghai, China; Taipei, Taiwan; and Tokyo, Japan, the firm practices all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation. Finnegan also represents clients on IP issues related to international trade, portfolio management, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com. Follow us on LinkedIn or on Twitter.
###
Media Mention
Women in Business Law Americas Awards 2024: Three Finnegan Attorneys Shortlisted
April 7, 2024
Press Release
Finnegan and BMW Group Successfully Demolish Non-Practicing Entity NorthStar’s Efforts
April 3, 2024
Award/Ranking
Managing IP Americas Awards 2024: Finnegan Shortlisted for Nine Awards, Including Firm of the Year
March 12, 2024
Commentary
February 29, 2024
Press Release
Finnegan Secures Another Patent Victory for BMW Group in the District of Delaware
February 27, 2024
Award/Ranking
Managing IP EMEA Awards 2024: Finnegan Shortlisted for Global Firm of the Year Award
February 19, 2024
Press Release
February 13, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.